729 research outputs found
Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.
Autosomal dominant Alzheimer's disease (ADAD) is a small subset of Alzheimer's disease that is genetically determined with 100% penetrance. It provides a valuable window into studying the course of pathologic processes that leads to dementia. Arterial spin labeling (ASL) MRI is a potential AD imaging marker that non-invasively measures cerebral perfusion. In this study, we investigated the relationship of cerebral blood flow measured by pseudo-continuous ASL (pCASL) MRI with measures of cerebral metabolism (FDG PET) and amyloid deposition (Pittsburgh Compound B (PiB) PET). Thirty-one participants at risk for ADAD (age 39 ± 13 years, 19 females) were recruited into this study, and 21 of them received both MRI and FDG and PiB PET scans. Considerable variability was observed in regional correlations between ASL-CBF and FDG across subjects. Both regional hypo-perfusion and hypo-metabolism were associated with amyloid deposition. Cross-sectional analyses of each biomarker as a function of the estimated years to expected dementia diagnosis indicated an inverse relationship of both perfusion and glucose metabolism with amyloid deposition during AD development. These findings indicate that neurovascular dysfunction is associated with amyloid pathology, and also indicate that ASL CBF may serve as a sensitive early biomarker for AD. The direct comparison among the three biomarkers provides complementary information for understanding the pathophysiological process of AD
Combined renin inhibition/(Pro)renin receptor blockade in diabetic retinopathy- a study in transgenic (mREN2)27 rats
Dysfunction of renin-angiotensin system (RAS) contributes to the pathogenesis of diabetic retinopathy (DR). Prorenin, the precursor of renin is highly elevated in ocular fluid of diabetic patients with proliferative retinopathy. Prorenin may exert local effects in the eye by binding to the so-called (pro)renin receptor ((P)RR). Here we investigated the combined effects of the renin inhibitor aliskiren and the putative (P)RR blocker handle-region peptide (HRP) on diabetic retinopathy in streptozotocin (STZ)-induced diabetic transgenic (mRen2)27 rats (a model with high plasma prorenin levels) as well as prorenin stimulated cytokine expression in cultured Müller cells. Adult (mRen2)27 rats were randomly divided into the following groups: (1) non-diabetic; (2) diabetic treated with vehicle; (3) diabetic treated with aliskiren (10 mg/kg per day); and (4) diabetic treated with aliskiren+HRP (1 mg/kg per day). Age-matched non-diabetic wildtype Sprague-Dawley rats were used as control. Drugs were administered by osmotic minipumps for three weeks. Transgenic (mRen2)27 rat retinas showed increased apoptotic cell death of both inner retinal neurons and photoreceptors, increased loss of capillaries, as well as increased expression of inflammatory cytokines. These pathological changes were further exacerbated by diabetes. Aliskiren treatment of diabetic (mRen2)27 rats prevented retinal gliosis, and reduced retinal apoptotic cell death, acellular capillaries and the expression of inflammatory cytokines. HRP on top of aliskiren did not provide additional protection. In cultured Müller cells, prorenin significantly increased the expression levels of IL-1α and TNF-α, and this was completely blocked by aliskiren or HRP, their combination, (P)RR siRNA and the AT1R blocker losartan, suggesting that these effects entirely depended on Ang II generation by (P)RR-bound prorenin. In conclusion, the lack of effect of HRP on top of aliskiren, and the Ang II-dependency of t
Impact of CYP2C:TG Haplotype on CYP2C19 substrates clearance in vivo, protein content, and in vitro activity
A novel haplotype composed of two non-coding variants, CYP2C18 NM_000772.3:c.*31T (rs2860840) and
NM_000772.2:c.819+2182G (rs11188059), referred to as “CYP2C:TG,” was recently associated with ultrarapid
metabolism of various CYP2C19 substrates. As the underlying mechanism and clinical relevance of this effect
remain uncertain, we analyzed existing in vivo and in vitro data to determine the magnitude of the CYP2C:TG
haplotype effect. We assessed variability in pharmacokinetics of CYP2C19 substrates, including citalopram,
sertraline, voriconazole, omeprazole, pantoprazole, and rabeprazole in 222 healthy volunteers receiving one of these
six drugs. We also determined its impact on CYP2C8, CYP2C9, CYP2C18, and CYP2C19 protein abundance in 135
human liver tissue samples, and on CYP2C18/CYP2C19 activity in vitro using N-desmethyl atomoxetine formation.
No effects were observed according to CYP2C:TG haplotype or to CYP2C19*1+TG alleles (i.e., CYP2C19 alleles
containing the CYP2C:TG haplotype). In contrast, CYP2C19 intermediate (e.g., CYP2C19*1/*2) and poor metabolizers
(e.g., CYP2C19*2/*2) showed significantly higher exposure in vivo, lower CYP2C19 protein abundance in human
liver microsomes, and lower activity in vitro compared with normal, rapid (i.e., CYP2C19*1/*17), and ultrarapid
metabolizers (i.e., CYP2C19*17/*17). Moreover, a tendency toward lower exposure was observed in ultrarapid
metabolizers compared with rapid metabolizers and normal metabolizers. Furthermore, when the CYP2C19*17
allele was present, CYP2C18 protein abundance was increased suggesting that genetic variation in CYP2C19 may
be relevant to the overall metabolism of certain drugs by regulating not only its expression levels, but also those of
CYP2C18. Considering all available data, we conclude that there is insufficient evidence supporting clinical CYP2C:TG
testing to inform drug therapyP.S.-C. is financed by Universidad Autónoma de Madrid (FPIUAM, 2021). P.Z. is financed by Universidad Autónoma de Madrid,
Margarita Salas contract, grants for the requalification of the
Spanish university system. A.R.-L. and E.G.-I. contracts are financed
by Programa Investigo (NextGenerationEU funds of the Recovery
and Resilience Facility), fellowship numbers 2022-C23.I01.P03.
S0020–0000031 and 09-PIN1-00015.6/2022. Human liver tissue
samples were obtained through the Liver Tissue Cell Distribution
System, Minneapolis, MN, and Pittsburgh, PA, which was funded by NIH
Contract #HHSN276201200017C. The proteomics part of the work was
supported by Eunice Kennedy Shriver National Institute of Child Health
and Human Development (NICHD), National Institutes of Health (NIH)
Grant R01.HD08129
Understanding local ethnic inequalities in childhood BMI through cross-sectional analysis of routinely collected local data
Carnegie Supernova Project-II: The Near-infrared Spectroscopy Program
Shifting the focus of Type Ia supernova (SN Ia) cosmology to the
near-infrared (NIR) is a promising way to significantly reduce the systematic
errors, as the strategy minimizes our reliance on the empirical
width-luminosity relation and uncertain dust laws. Observations in the NIR are
also crucial for our understanding of the origins and evolution of these
events, further improving their cosmological utility. Any future experiments in
the rest-frame NIR will require knowledge of the SN Ia NIR spectroscopic
diversity, which is currently based on a small sample of observed spectra.
Along with the accompanying paper, Phillips et al. (2018), we introduce the
Carnegie Supernova Project-II (CSP-II), to follow up nearby SNe Ia in both the
optical and the NIR. In particular, this paper focuses on the CSP-II NIR
spectroscopy program, describing the survey strategy, instrumental setups, data
reduction, sample characteristics, and future analyses on the data set. In
collaboration with the Harvard-Smithsonian Center for Astrophysics (CfA)
Supernova Group, we obtained 661 NIR spectra of 157 SNe Ia. Within this sample,
451 NIR spectra of 90 SNe Ia have corresponding CSP-II follow-up light curves.
Such a sample will allow detailed studies of the NIR spectroscopic properties
of SNe Ia, providing a different perspective on the properties of the unburned
material, radioactive and stable nickel produced, progenitor magnetic fields,
and searches for possible signatures of companion stars.Comment: 20 pages, 7 figures, accepted for publication in PAS
Recommended from our members
HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype.
Aortic calcification is an important independent predictor of future cardiovascular events. We performed a genome-wide association meta-analysis to determine SNPs associated with the extent of abdominal aortic calcification (n = 9,417) or descending thoracic aortic calcification (n = 8,422). Two genetic loci, HDAC9 and RAP1GAP, were associated with abdominal aortic calcification at a genome-wide level (P < 5.0 × 10-8). No SNPs were associated with thoracic aortic calcification at the genome-wide threshold. Increased expression of HDAC9 in human aortic smooth muscle cells promoted calcification and reduced contractility, while inhibition of HDAC9 in human aortic smooth muscle cells inhibited calcification and enhanced cell contractility. In matrix Gla protein-deficient mice, a model of human vascular calcification, mice lacking HDAC9 had a 40% reduction in aortic calcification and improved survival. This translational genomic study identifies the first genetic risk locus associated with calcification of the abdominal aorta and describes a previously unknown role for HDAC9 in the development of vascular calcification
Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers
Heterogeneity of cancer stem/progenitor cells that give rise to different forms of cancer has been well demonstrated for leukemia. However, this fundamental concept has yet to be established for solid tumors including breast cancer. In this communication, we analyzed solid tumor cancer stem cell markers in human breast cancer cell lines and primary specimens using flow cytometry. The stem/progenitor cell properties of different marker expressing-cell populations were further assessed by in vitro soft agar colony formation assay and the ability to form tumors in NOD/SCID mice. We found that the expression of stem cell markers varied greatly among breast cancer cell lines. In MDA-MB-231 cells, PROCR and ESA, instead of the widely used breast cancer stem cell markers CD44+/CD24-/low and ALDH, could be used to highly enrich cancer stem/progenitor cell populations which exhibited the ability to self renew and divide asymmetrically. Furthermore, the PROCR+/ESA+ cells expressed epithelial-mesenchymal transition markers. PROCR could also be used to enrich cells with colony forming ability from MB-361 cells. Moreover, consistent with the marker profiling using cell lines, the expression of stem cell markers differed greatly among primary tumors. There was an association between metastasis status and a high prevalence of certain markers including CD44+/CD24−/low, ESA+, CD133+, CXCR4+ and PROCR+ in primary tumor cells. Taken together, these results suggest that similar to leukemia, several stem/progenitor cell-like subpopulations can exist in breast cancer
- …